BGMS
Price
$0.87
Change
-$0.03 (-3.33%)
Updated
Nov 3 closing price
Capitalization
5.78M
9 days until earnings call
Intraday BUY SELL Signals
KAPA
Price
$0.49
Change
+$0.02 (+4.26%)
Updated
Nov 3, 04:53 PM (EDT)
Capitalization
1.6M
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BGMS vs KAPA

BGMS vs KAPA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BGMS vs. KAPA commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGMS is a Hold and KAPA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BGMS with price predictions
Nov 03, 2026

BGMS sees its Stochastic Oscillator ascending out of oversold territory

On November 03, 2026, the Stochastic Oscillator for BGMS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 67 instances where the indicator left the oversold zone. In 60 of the 67 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for BGMS crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.

Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where BGMS advanced for three days, in 182 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

BGMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BGMS as a result. In 79 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for BGMS turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 43 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

BGMS moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BGMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.807) is normal, around the industry mean (3.000). P/E Ratio (-0.091) is within average values for comparable stocks, (25.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.215). Dividend Yield (0.000) settles around the average of (0.079) among similar stocks. P/S Ratio (2.410) is also within normal values, averaging (1.867).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. BGMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

A.I.Advisor
a Summary for KAPA with price predictions
Nov 02, 2026

KAPA in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 06, 2026

KAPA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 12 of 14 cases where KAPA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for KAPA just turned positive on October 28, 2026. Looking at past instances where KAPA's MACD turned positive, the stock continued to rise in 18 of 22 cases over the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KAPA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for KAPA entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.382) is normal, around the industry mean (3.104). P/E Ratio (-0.242) is within average values for comparable stocks, (-0.958). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.907) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. KAPA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KAPA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
BGMS: Fundamental Ratings
BGMS
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGMSKAPA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 7 days ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (BGMS: $0.87 vs. KAPA: $0.47)
Brand notoriety: BGMS and KAPA are both not notable
BGMS represents the Building Products, while KAPA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: BGMS: 27% vs. KAPA: 19%
Market capitalization -- BGMS: $5.78M vs. KAPA: $1.6M
BGMS [@Building Products] is valued at $5.78M. KAPA’s [@Biotechnology] market capitalization is $1.6M. The market cap for tickers in the [@Building Products] industry ranges from $1.88K to $90.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $140.2B. The average market capitalization across the [@Building Products] industry is $9.62B. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGMS’s FA Score shows that 1 FA rating(s) are green while KAPA’s FA Score has 0 green FA rating(s).

  • BGMS’s FA Score: 1 green, 4 red.
  • KAPA’s FA Score: 0 green, 5 red.
According to our system of comparison, BGMS is a better buy in the long-term than KAPA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGMS’s TA Score shows that 4 TA indicator(s) are bullish while KAPA’s TA Score has 4 bullish TA indicator(s).

  • BGMS’s TA Score: 4 bullish, 4 bearish.
  • KAPA’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, KAPA is a better buy in the short-term than BGMS.

Price Growth

BGMS (@Building Products) experienced а -7.59% price change this week, while KAPA (@Biotechnology) price change was -11.68% for the same time period.

The average weekly price growth across all stocks in the @Building Products industry was -2.16%. For the same industry, the average monthly price growth was -2.28%, and the average quarterly price growth was -16.12%.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.06%. For the same industry, the average monthly price growth was -12.02%, and the average quarterly price growth was -17.00%.

Reported Earning Dates

BGMS is expected to report earnings on Nov 12, 2026.

KAPA is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Building Products (-2.16% weekly)

The industry manufactures products used in the construction of residential and commercial buildings. The process involves using materials and other products, and processing them to create finished items such as doors, windows, light fittings, floor coverings, climate control products and other building components and home improvement products. Masco Corporation, Allegion PLC and Lennox International Inc. are major manufacturers of such products.

@Biotechnology (-2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BGMS
Daily Signal:
Gain/Loss:
KAPA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

KAPA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KAPA has been loosely correlated with INKT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KAPA jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAPA
1D Price
Change %
KAPA100%
+6.65%
INKT - KAPA
50%
Loosely correlated
+1.51%
BGMS - KAPA
46%
Loosely correlated
-3.11%
RXRX - KAPA
31%
Poorly correlated
-3.92%
ENSC - KAPA
28%
Poorly correlated
-1.15%
TCRT - KAPA
27%
Poorly correlated
+6.29%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRAI3.070.57
+22.80%
Braiin Limited
YDKG1.000.11
+12.36%
Yueda Digital Holding
EXEL72.312.18
+3.11%
Exelixis
PYPD5.460.04
+0.74%
PolyPid Ltd
TLX9.03-0.02
-0.22%
Telix Pharmaceuticals Ltd.